🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

More accolades for CBC affiliate, @CathyNagler, The University of Chicago who made the Crain’s Tech 50 of 2018 list! Congratulations! UChicago News UChicago Research ClostraBio

Successful companies like Grubhub & Braintree both received help from the @PolksyCenter. Now #startup ClostraBio is hoping to see similar success. Learn more about the #entrepreneur resources available in #Chicago — via Pete Wilkins for Forbes:

A huge, huge congratulations to our co-founder, Jeffrey Hubbell, who was just elected the #NationalAcademyOfMedicine! National Academy of Medicine nam.edu/national-acade…

Our very own Jeffrey Hubbell on this list! #NAMmtg

Huge CONGRATS to The University of Chicago Jeffrey Hubbell on being named to National Academy of Medicine. We are #PolskyProud news.uchicago.edu/story/jeffrey-…

. The University of Chicago researchers find that gut microbes from healthy human infant donors transplanted into mice protected animals exposed to milk from experiencing allergic reactions: ow.ly/x2Dh30nk16E

Congrats @CathyNagler, our co-founder, who just published her work in Nature Medicine showing how healthy infants have intestinal bacteria that are protective against #foodallergy! #microbiome

Congrats @CathyNagler! #polskyproud

#ICYMI: @CathyNagler's research appears in Nature Medicine this week. Great explanation of her work and why it's so important in Discover Magazine. #foodallergy #microbiome #newtherapies

Covered in C&EN (Chemical & Engineering News)!

We are #PolskyProud! Glad we could be at the forefront of the Launchpad Polsky Center at the University of Chicago! polsky.uchicago.edu/2019/02/28/pol…

we are here at #BIO2019 and the #startupstadium with fellow Polsky Center at the University of Chicago and The University of Chicago spinout Seurat Therapeutics. Come check it out! Booth 3971 in Hall E.

ClostraBio is delighted to see our co-founder @CathyNagler's seminal work recognized among the key milestones in the microbiome field (see Milestone 9, 2004, Regulation of Mucosal Immunity by the Microbiota).

John Colson ClostraBio continues the conversation in Track A to demonstrate the benefits of using Microbiota-derived polymers that show potential prevention against allergic sensitisation #MicrobiomeMVNT

ClostraBio is thrilled to have been named a winner at the #BIO2019 #StartUpStadium! convention.bio.org/startup/

ClostraBio is thrilled to announce that we are winners of our session at the #BIO2019 #StartUpStadium!

#Startup companies can bring basic science to real-life impact. No one is doing this for us — We have to do it for ourselves. - @CathyNagler, cofounder of ClostraBio #foodallergy #foodallergies

Excited to share that our co-founder, @CathyNagler, is being honored in Crain's Notable Women in Health Care chicagobusiness.com/awards/crains-… via Crain's Chicago Business

“I want the development of a drug to treat food allergy to be the capstone project of my career,” said Cathryn Nagler, PhD. ms.spr.ly/6019TZijt

Huge news from our portfolio company, ClostraBio! They announced a major breakthrough in delivering metabolite to the gastrointestinal tract, as well as appointing a CEO. Take a look at the release here: ow.ly/i3jv50Mzlt0 #biotech #foodallergies #IBD